Grants paid by National Tay-Sachs & Allied Diseases Ass
EIN 13-1912877 · Brighton, MA · Form 990, Schedule I · NTEE G2XZ
National Tay-Sachs & Allied Diseases Ass of Brighton, MA (EIN 13-1912877) reported 55 grants paid totaling $1,009,178 to 16 recipients in tax years 2018–2023, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$1,009,178
55 grants
Recipients
16
distinct organizations
Tax years
2018–2023
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 11 | $289,154 | — |
| 2019 | 12 | $137,232 | — |
| 2020 | 14 | $142,500 | — |
| 2021 | 15 | $129,500 | — |
| 2023 | 3 | $310,792 | — |
Top recipients
The 16 recipients receiving the most from National Tay-Sachs & Allied Diseases Ass, by grants paid, out of 16 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| University of Massachusetts Medical School 04-3167352 | A | Worcester, MA | 5 | $318,912 | 2023 |
| Auburn University 63-6000724 | A | Auburn, AL | 5 | $145,600 | 2023 |
| Mass General Hospital 04-2697983 | A | Charlestown, MA | 5 | $112,828 | 2023 |
| Washington University 43-0653611 | A | St Louis, MO | 3 | $80,000 | 2021 |
| St Jude Childrens Research Hospital 62-0646012 | A | Memphis, TN | 3 | $80,000 | 2021 |
| Dana-Farber Cancer Institute 04-2263040 | A | Boston, MA | 4 | $48,000 | 2021 |
| Weizmann Institute of Science 01-1301390 | A | Rehovot, ISRAEL | 1 | $48,000 | 2021 |
| National Human Genome Research Institute 22-3524710 | A | Bethesda, MD | 2 | $35,000 | 2021 |
| Greenwood Genetic Center 57-0604070 | A | Greenwood, SC | 4 | $30,000 | 2021 |
| University of Maryland School of Medicine 31-1678679 | A | Baltimore, MD | 2 | $21,000 | 2021 |
| Children's Hospital of Philadelphia 23-1352166 | A | Philadelphia, PA | 4 | $19,971 | 2021 |
| Queen's University | U | Kingston, ONTARIO | 1 | $16,000 | 2018 |
| University of Pa 23-1352685 | A | Philadelphia, PA | 4 | $14,923 | 2021 |
| Biostrategies Lc 27-0000245 | A | State University, AR | 4 | $14,400 | 2021 |
| Emory University 58-0566256 | A | Atlanta, GA | 4 | $13,000 | 2021 |
| New York University School of Medicine 13-5562308 | A | Boston, MA | 4 | $11,544 | 2021 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 55 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | Umass Chan Medical Center Worcester, MA | A | $142,875 | paid | LYSOMAL STORAGE DISEASE RESEARCH | 202401359349305915 |
| 2023 | Auburn University Al Auburn, AL | A | $112,000 | paid | LYSOMAL STORAGE DISEASE RESEARCH | 202401359349305915 |
| 2023 | Mgh Inst of Health Professions Charlestown, MA | A | $55,917 | paid | LYSOMAL STORAGE DISEASE RESEARCH | 202401359349305915 |
| 2021 | Weizmann Institute of Science Rehovot, ISRAEL | A | $48,000 | paid | ROLE OF MICROGLIA IN SANDHOFF DISEASE PATHOLOGY | 202133079349302148 |
| 2021 | Washington University St Louis, MO | A | $32,000 | paid | OLIGOSACCHARIDE BIOMARKERS FOR DISEASE PROGRESSION | 202133079349302148 |
| 2021 | St Jude Childrens Research Hospital Memphis, TN | A | $32,000 | paid | ROLE OF THE PLASMA MEMBRANE-ER CONTACT SITES IN GM1-MEDIATED NEURONAL CELL DEATH | 202133079349302148 |
| 2021 | National Human Genome Research Institute Bethesda, MD | A | $17,500 | paid | LATE ONSET TAY-SACHS AND SANDHOFF RESEARCH | 202133079349302148 |
| 2021 | Children's Hospital of Philadelphia Philadelphia, PA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | University of Maryland School of Medicine Baltimore, MD | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | Mass General Hospital Charlestown, MA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | University of Massachusetts Medical School Worcester, MA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | Dana-Farber Cancer Institute Boston, MA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | Biostrategies Lc State University, AR | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | University of Pa Philadelphia, PA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | Emory University Atlanta, GA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | Greenwood Genetic Center Greenwood, SC | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | New York University School of Medicine Boston, MA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2021 | Auburn University Auburn, AL | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202133079349302148 |
| 2020 | University of Massachusetts Medical School Worcester, MA | A | $48,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | St Jude Childrens Research Hospital Memphis, TN | A | $24,000 | paid | ROLE OF THE PLASMA MEMBRANE-ER CONTACT SITES IN GM1-MEDIATED NEURONAL CELL DEATH | 202140639349301704 |
| 2020 | University of Maryland School of Medicine Baltimore, MD | A | $21,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | National Human Genome Research Institute Bethesda, MD | A | $17,500 | paid | LATE ONSET TAY-SACHS AND SANDHOFF RESEARCH | 202140639349301704 |
| 2020 | Washington University St Louis, MO | A | $16,000 | paid | OLIGOSACCHARIDE BIOMARKERS FOR DISEASE PROGRESSION | 202140639349301704 |
| 2020 | Dana-Farber Cancer Institute Boston, MA | A | $16,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | Auburn University Auburn, AL | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | Mass General Hospital Charlestown, MA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | Biostrategies Lc State University, AR | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | New York University School of Medicine Boston, MA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | Greenwood Genetic Center Greenwood, SC | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | Children's Hospital of Philadelphia Philadelphia, PA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | University of Pa Philadelphia, PA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2020 | Emory University Atlanta, GA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202140639349301704 |
| 2019 | University of Massachusetts Medical School Worcester, MA | A | $36,450 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | Washington University St Louis, MO | A | $32,000 | paid | OLIGOSACCHARIDE BIOMARKERS FOR DISEASE PROGRESSION | 202020569349301407 |
| 2019 | Mass General Hospital Charlestown, MA | A | $26,811 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | St Jude Childrens Research Hospital Memphis, TN | A | $24,000 | paid | ROLE OF THE PLASMA MEMBRANE-ER CONTACT SITES IN GM1-MEDIATED NEURONAL CELL DEATH | 202020569349301407 |
| 2019 | Children's Hospital of Philadelphia Philadelphia, PA | A | $9,971 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | Dana-Farber Cancer Institute Boston, MA | A | $8,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | Auburn University Auburn, AL | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | Greenwood Genetic Center Greenwood, SC | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | New York University School of Medicine Boston, MA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | University of Pa Philadelphia, PA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | Biostrategies Lc State University, AR | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2019 | Emory University Atlanta, GA | A | $0 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 202020569349301407 |
| 2018 | University of Massachusetts Medical School Worcester, MA | A | $91,587 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Auburn University Auburn, AL | A | $33,600 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Mass General Hospital Charlestown, MA | A | $30,100 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Greenwood Genetic Center Greenwood, SC | A | $30,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Dana-Farber Cancer Institute Boston, MA | A | $24,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Queen's University Kingston, ONTARIO | U | $16,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | University of Pa Philadelphia, PA | A | $14,923 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Biostrategies Lc State University, AR | A | $14,400 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Emory University Atlanta, GA | A | $13,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | New York University School of Medicine Boston, MA | A | $11,544 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
| 2018 | Children's Hospital of Philadelphia Philadelphia, PA | A | $10,000 | paid | LYSOSOMAL STORAGE DISEASE RESEARCH | 201900859349300015 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2023 | 2023-06-30 | not stated | 2022v5.0 | 202401359349305915 |
| 990 | 2021 | 2021-06-30 | not stated | 2020v4.1 | 202133079349302148 |
| 990 | 2020 | 2020-06-30 | not stated | 2019v5.2 | 202140639349301704 |
| 990 | 2019 | 2019-06-30 | not stated | 2018v3.1 | 202020569349301407 |
| 990 | 2018 | 2018-06-30 | not stated | 2017v2.3 | 201900859349300015 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/131912877.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.